ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivo. (Q40450045)
Jump to navigation
Jump to search
scientific article published on March 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivo. |
scientific article published on March 2005 |
Statements
1 reference
ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivo. (English)
1 reference
Thomas F Gajewski
1 reference
Christian Blank
1 reference
Ian Brown
1 reference
Aalok K Kacha
1 reference
Mary A Markiewicz
1 reference
1 March 2005
1 reference
1 reference
Identifiers
1 reference